![](\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2023\/01\/MM_Bill_Tracker_V5_blank-56.jpg\"){kind=tracking}
<\/p>\n <\/p>\n
The governor of New York recently signed legislation mandating that the state immediately reschedule or deschedule Schedule I drugs like MDMA and psilocybin if they\u2019re reclassified under federal law.<\/p>\n
The companion Assembly and Senate bills, signed by Gov. Kathy Hochul (D) late last month, are meant to \u201cprovide for parity between the New York State schedule and the federal schedule when certain drugs are approved for medical treatment,\u201d a memo from the sponsors says.<\/p>\n
Assemblymember Donna Lupardo (D) and Sen. Gustavo Rivera (D) sponsored the identical proposals in their respective chambers, carrying them through the committee process and to the floor with unanimous support. Hochul\u2019s action was first noted<\/a> by Lucid News this week.<\/p>\n While the newly enacted law<\/a> applies<\/a> to all Schedule I drugs, the sponsor memo explicitly references MDMA and psilocybin as examples of the types of substances that prompted lawmakers to advance the reform.<\/p>\n Now, if federal drug scheduling statute changes while the state legislature is out of session, the \u201cdrug products will be available for administration by medical providers to ensure that there are no gaps in services.\u201d<\/p>\n \u2014 The state health commissioner would be responsible for redesignating the substances \u201cusing regulatory action upon federal scheduling or rescheduling by the Drug Enforcement Administration (DEA),\u201d the bill memo says, noting that the move aligns New York\u2019s drug scheduling policy with 23 other states that already automatically comport with the federal Controlled Substances Act<\/p>\n \u201cWithout the statutory authority to automatically classify or reclassify certain drug products, New Yorkers might experience a delay in accessing and benefitting from federally approved breakthrough therapies, such as MDMA-assisted therapies for post-traumatic stress disorder or psilocybin treatment for depression,\u201d the sponsors wrote.<\/p>\n The bill text itself is fairly straightforward, simply amending existing statute to say the commissioner \u201cshall\u201d take the scheduling action, rather than \u201cmay.\u201d<\/p>\n Colorado\u2019s governor signed a similar but more limited reform into law<\/a> last year, making it so the state will legalize MDMA prescriptions pending a federal policy change.<\/p>\n Meanwhile, New York lawmakers are actively pursuing broader psychedelics reform<\/a> for the 2023 session, with Assemblymember Linda Rosenthal (D) pre-filing legislation late last month to legalize certain entheogenic substances like psilocybin and ibogaine for adults 21 and older.<\/p>\n The proposal would amend state statute to make legal the \u201cpossession, use, cultivation, production, creation, analysis, gifting, exchange, or sharing by or between natural persons of twenty-one years of age or older of a natural plant or fungus-based hallucinogen.\u201d<\/p>\n Rosenthal has taken special interest in psychedelic policy in recent years. For example, she filed a bill in 2021 that would have simply removed psilocybin and psilocyn from the state\u2019s list of controlled substances, effectively legalizing the compounds<\/a>.<\/p>\n But she revised that measure in October,\u00a0filing language that is substantially similar<\/a>\u00a0to this latest legislation for the 2023 legislative session.<\/p>\n Rosenthal separately introduced a bill in 2021 that would create a \u201cpsychedelic research institute\u201d<\/a>\u00a0tasked with studying the therapeutic potential of the substances for certain conditions and making policy recommendations.<\/p>\n She and Assemblymember Pat Burke (D), who sponsored another\u00a0measure to legalize the medical use of psilocybin<\/a>\u00a0for certified patients in clinical settings,\u00a0participated in a psychedelics symposium earlier this year<\/a>\u00a0and discussed their competing proposals.<\/p>\n Burke is expected to soon file a new version of his legislation, and believes he has enough votes to advance it out of committee, according to Lucid.<\/p>\n The new drug scheduling legislation was signed by the governor about a week before the state\u2019s adult-use marijuana market launched<\/a>.<\/p>\n Outside of New York, bipartisan lawmakers in a growing number of states have started pursuing psychedelics reform for the 2023 session, building on the local decriminalization movement that began in earnest in 2019 when Denver became the first U.S. city to enact the policy change for psilocybin.<\/p>\n Oregon voters approved a historic ballot initiative to legalize psilocybin for therapeutic use in 2020, and Colorado voters passed a broad psychedelics legalization and psilocybin services measure during the November election.<\/p>\n Now lawmakers are picking up the mantle, with psychedelics reform legislation in play in about a dozen states so far<\/a>.<\/p>\n An analysis published in an American Medical Association journal last month concluded that a majority of states will legalize psychedelics<\/a>\u00a0by 2037, based on statistical modeling of policy trends.<\/p>\n Pennsylvania Governor Touts Hundreds Of Marijuana Pardons As He Leaves Office<\/a><\/p>\n<\/blockquote>\n\n The post New York Governor Signs Bill To Mandate State Legalization Of Schedule I Drugs Like Psilocybin And MDMA If Federal Law Changes<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n
The governor of New York recently signed legislation mandating that the state immediately reschedule or deschedule Schedule I drugs like MDMA and psilocybin if they\u2019re reclassified under federal law. The companion Assembly and Senate bills, signed by Gov. Kathy Hochul (D) late last month, are meant to \u201cprovide for parityContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":60694,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,81],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/60693"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=60693"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/60693\/revisions"}],"predecessor-version":[{"id":60695,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/60693\/revisions\/60695"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media\/60694"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=60693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=60693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=60693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMarijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills<\/a> in state legislatures and Congress this year. Patreon supporters<\/a> pledging at least $25\/month get access to our interactive maps, charts and hearing calendar so they don\u2019t miss any developments.
\n![\"\"](\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2023\/01\/MM_Bill_Tracker_V5_blank-55.jpg\"){kind=tracking}
<\/a>
\nLearn more about our marijuana bill tracker<\/a> and become a supporter on Patreon<\/a> to get access.
\n\u2014<\/strong><\/p>\n\n
\n
\nRead More: New York Governor Signs Bill To Mandate State Legalization Of Schedule I Drugs Like Psilocybin And MDMA If Federal Law Changes<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"